Nemolizumab (Nemluvio) relieved itchiness within two days for three times as many patients as a placebo, researchers reported Tuesday in the Journal of the European Academy of Dermatology and ...
Both cabotegravir and Truvada were generally safe and well-tolerated. Study participants who received cabotegravir were more likely than those who received placebo shots to report pain and tenderness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results